[Click eStock] "Amicogen, Expected Growth in Cell Culture Media and Purification Resin"

Research Alom forecasted on the 23rd that Amicogen's sales of cell culture media and purification resins will gradually increase.

Researcher Kim Jaemu of Research Alom introduced, "Cell culture media is used in the culturing process and serves as the growth substance and nutrient necessary for cells in all production stages of biopharmaceuticals." He added, "The domestic media market is dominated by foreign companies such as Germany's MERCK and SARTORIUS, and the United States' Thermo Fisher Scientific and Cytiva," and "Amicogen has been carrying out a national project for the localization of biopharmaceutical media since 2020."

He stated, "In September 2020, Amicogen established Beyondcell with Artiabio, a U.S. company possessing media production technology," emphasizing, "Amicogen's media has the biggest advantage of being cheaper compared to competitors." Additionally, "we are continuously conducting tests with domestic CDMO companies," and "customer feedback has been positive," he analyzed.

Researcher Kim said, "Meaningful sales are expected by the end of the first quarter next year," adding, "Due to the nature of biopharmaceutical approval procedures, it is difficult to replace the culture media used at the time of approval with another product." He also stated, "It is difficult for Amicogen media to enter the production of existing drugs," and "it is judged that it will enter the development and clinical stages of new drugs or new biosimilars."

Researcher Kim also explained, "Resin is used in the purification process to remove impurities," and "production of resin will begin from the first quarter of next year for domestic sales." Furthermore, he emphasized, "We are currently conducting supply contracts worth 2 to 3 billion KRW annually," and "companies in China and India are conducting tests."